What Do Clinical Trials and Mechanistic Evidence Teach Us About Efficacy of Short-Acting GLP-1 Receptor Agonists for Managing PPG in Diabetic Patients Already on Basal Insulin?

What Do Clinical Trials and Mechanistic Evidence Teach Us About Efficacy of Short-Acting GLP-1 Receptor Agonists for Managing PPG in Diabetic Patients Already on Basal Insulin?


Published

April 28, 2017

Created by

CMEducation Resources symposium